Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

196 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Profiles and Outcomes of Skin Injuries Caused by Injectable Drug Extravasation: An Analysis of the Japanese Adverse Drug Event Report Database.
Maezawa M, Inoue M, Satake R, Wakabayashi W, Oura K, Miyasaka K, Hirofuji S, Goto F, Iwata M, Suzuki T, Tanaka H, Horibe M, Nakao S, Tsuji T, Ieiri I, Iguchi K, Nakamura M. Maezawa M, et al. Among authors: ieiri i. J Infus Nurs. 2023 Sep-Oct 01;46(5):281-293. doi: 10.1097/NAN.0000000000000517. J Infus Nurs. 2023. PMID: 37611286
Evaluation of neuroleptic malignant syndrome induced by antipsychotic drugs using spontaneous reporting system.
Hirofuji S, Miyasaka K, Maezawa M, Wakabayashi W, Oura K, Nakao S, Ichihara N, Nokura Y, Yamashita M, Matsui K, Tanaka H, Masuta M, Ieiri I, Iguchi K, Nakamura M. Hirofuji S, et al. Among authors: ieiri i. Heliyon. 2023 Nov 7;9(11):e21891. doi: 10.1016/j.heliyon.2023.e21891. eCollection 2023 Nov. Heliyon. 2023. PMID: 38034668 Free PMC article.
Risk Factor for Rash in Patients Receiving Cytarabine and Idarubicin Induction Therapy for Acute Myeloid Leukemia.
Uchida M, Ishida S, Mochizuki E, Ozawa N, Yonemitsu H, Ochiai H, Nakamura H, Kawashiri T, Watanabe H, Tsuji T, Suetsugu K, Kato K, Egashira N, Akashi K, Ieiri I. Uchida M, et al. Among authors: ieiri i. Cancer Diagn Progn. 2024 Sep 1;4(5):617-622. doi: 10.21873/cdp.10372. eCollection 2024 Sep-Oct. Cancer Diagn Progn. 2024. PMID: 39238617 Free PMC article.
Safety and efficacy of ripasudil eye drops in preterm infants with retinopathy of prematurity: phase 1/2, open label, single-arm trial.
Arima M, Inoue H, Misumi A, Tsukamoto S, Matsushita I, Araki S, Ohta M, Takahashi K, Imazato M, Goto T, Aoki Y, Tagawa K, Hirose M, Fujita Y, Yoshida N, Nakao S, Kondo H, Kusuhara K, Kimura K, Hasegawa S, Ikeda Y, Kodama Y, Moritake H, Ochiai M, Ohga S, Kishimoto J, Todaka K, Ieiri I, Sonoda KH. Arima M, et al. Among authors: ieiri i. Jpn J Ophthalmol. 2024 Sep;68(5):490-499. doi: 10.1007/s10384-024-01100-3. Epub 2024 Jul 26. Jpn J Ophthalmol. 2024. PMID: 39060675 Clinical Trial.
Safety and tolerability of OP-724 in patients with haemophilia and liver cirrhosis due to HIV/HCV coinfection: an investigator-initiated, open-label, non-randomised, single-centre, phase I study.
Kimura K, Tanuma J, Kimura M, Imamura J, Yanase M, Ieiri I, Kurosaki M, Watanabe T, Endo T, Yotsuyanagi H, Gatanaga H. Kimura K, et al. Among authors: ieiri i. BMJ Open Gastroenterol. 2024 Apr 27;11(1):e001341. doi: 10.1136/bmjgast-2023-001341. BMJ Open Gastroenterol. 2024. PMID: 38677720 Free PMC article. Clinical Trial.
196 results